"Saint Agnes participates in a variety of different clinical trials/research, giving our patients access to some of the most modern treatment methods," said Dr. Carole B. Miller, director of the Cancer Insitute at St. Agnes. "The time period reviewed included funding from one pharmaceutical company for two 5-year clinical trials with one drug, which was approved by the FDA two years into the studies. Once approved by the FDA, costs increase which explains a great deal of the funding reported. The cost of the drug was realized as a cash equivalent to the hospital, but there was no financial benefit to the hospital and the hospital did not charge the patient for the drugs. The drug costs were strictly pass through."